Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Boehringer Ingelheim
Express Scripts
Covington
Chinese Patent Office
Johnson and Johnson

Generated: September 17, 2019

DrugPatentWatch Database Preview

Patent: 9,714,422

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 9,714,422
Title:Reducing intron retention
Abstract: Disclosed herein are methods, compositions, polynucleic acid polymers, assays, and kits for inducing processing of a partially processed mRNA transcript to remove a retained intron to produce a fully processed mRNA transcript that encodes a full-length functional form of a protein. Also described herein are methods and compositions for treating a disease or condition characterized by impaired production of a full-length functional form of a protein or for treating a disease or condition characterized by a defective splicing in a subject.
Inventor(s): Vorechovsky; Igor (Southampton, GB), Kralovicova; Jana (Southampton, GB)
Assignee: UNIVERSITY OF SOUTHAMPTON (Southampton, Hampshire, GB)
Application Number:15/148,303
Patent Claims:see list of patent claims

Details for Patent 9,714,422

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Schering INTRON A interferon alfa-2b VIAL 103132 001 1986-06-04 ➤ Sign Up UNIVERSITY OF SOUTHAMPTON (Southampton, Hampshire, GB) 2034-06-16 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 002 1986-06-04 ➤ Sign Up UNIVERSITY OF SOUTHAMPTON (Southampton, Hampshire, GB) 2034-06-16 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 003 1986-06-04 ➤ Sign Up UNIVERSITY OF SOUTHAMPTON (Southampton, Hampshire, GB) 2034-06-16 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Accenture
Argus Health
Cipla
Fuji
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.